ImportRefusal LogoImportRefusal

MEDICAL DEVELOPMENTS INTERNATIONAL

⚠️ Moderate Risk

FEI: 3005977696 • Scoresby, Victoria • AUSTRALIA

FEI

FEI Number

3005977696

📍

Location

Scoresby, Victoria

🇦🇺

Country

AUSTRALIA
🏢

Address

4 Caribbean Dr, , Scoresby, Victoria, Australia

Moderate Risk

FDA Import Risk Assessment

36.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

4
Total Refusals
4
Unique Violations
7/12/2021
Latest Refusal
1/3/2002
Earliest Refusal

Score Breakdown

Violation Severity
66.3×40%
Refusal Volume
25.9×30%
Recency
9.6×20%
Frequency
2.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

723×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
7/12/2021
60QDQ15METHOXYFLURANE (ANESTHETIC)
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/6/2005
64TIL08TACROLIMUS (IMMUNOSUPPRESSIVE)
72NEW VET DR
Minneapolis District Office (MIN-DO)
6/18/2004
60QIY99ANESTHETIC, N.E.C.
118NOT LISTED
72NEW VET DR
New York District Office (NYK-DO)
1/3/2002
68YAK10SMALL ANIMAL ANIMAL DRUGS N.E.C.
118NOT LISTED
72NEW VET DR
Chicago District Office (CHI-DO)

Frequently Asked Questions

What is MEDICAL DEVELOPMENTS INTERNATIONAL's FDA import refusal history?

MEDICAL DEVELOPMENTS INTERNATIONAL (FEI: 3005977696) has 4 FDA import refusal record(s) in our database, spanning from 1/3/2002 to 7/12/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. MEDICAL DEVELOPMENTS INTERNATIONAL's FEI number is 3005977696.

What types of violations has MEDICAL DEVELOPMENTS INTERNATIONAL received?

MEDICAL DEVELOPMENTS INTERNATIONAL has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about MEDICAL DEVELOPMENTS INTERNATIONAL come from?

All FDA import refusal data for MEDICAL DEVELOPMENTS INTERNATIONAL is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.